Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study)

Authors

Institutions

Publication Details

Journal
Clinics and Research in Hepatology and Gastroenterology
Published
2024-10-22
DOI
https://doi.org/10.1016/j.clinre.2024.102483
Citations
1
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study)

Stéphane Nancey, David Laharie, A. Bouzidi, M. Assing et al.
1 citations
Clinics and Research in Hepatology and Gastroenterology
Biosimilars and Bioanalytical Methods
0.24
article

Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study)

Stéphane Nancey, David Laharie, A. Bouzidi, M. Assing, Aurélien Amiot, Y. Brault, Yoram Bouhnik, Lucine Vuitton, Gaëlle Pierron, Amélie Biron
article en
1 citations

Abstract

No abstract available for this paper.
Clinics and Research in Hepatology and GastroenterologyVol. 48(10)
Université Claude Bernard Lyon 1 (FR), Inserm (FR), Université Paris-Saclay (FR), Hôpital Beaujon (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Assistance Publique – Hôpitaux de Paris (FR), Clinical Investigation Center Plurithematic Tours (FR), Hospices Civils de Lyon (FR), Centre de recherche en Epidémiologie et Santé des Populations (FR), Hôpital Lyon Sud (FR), Pfizer (France) (FR), Hôpital Cardiologique du Haut-Lévêque (FR), Pitié-Salpêtrière Hospital (FR), Hôpital Robert-Debré (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Clinique Hartmann (FR), Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR), Centre International de Recherche en Infectiologie (FR), Centre d'Investigation Clinique Plurithématique de Bordeaux, Institut Curie (FR), Université de Franche-Comté (FR), Université de Reims Champagne-Ardenne (FR)
Pfizer
Openalex Percentile: Top 41%
Biosimilars and Bioanalytical Methods
0.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.